Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

HBIO holding history

Harvard Bioscience Inc in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HBIO overviewAll 13F holders of HBIOFull Q2 2026 holdings

Shares (Q2 2026)
99,327
Value
$610.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of HBIO by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202699,327$610.9K<0.1%−2,100−2.1%ReducedHolders
Q1 2026101,427$493.9K<0.1%−697−0.7%ReducedConverted for a 1-for-10 splitHolders
Q4 20251,021,241$683.0K<0.1%+152,763+17.6%AddedHolders
Q3 2025868,478$380.8K<0.1%+76,500+9.7%AddedHolders
Q2 2025791,978$351.5K<0.1%−91,720−10.4%ReducedHolders
Q1 2025883,698$500.2K<0.1%+173,920+24.5%AddedHolders
Q4 2024709,778$1.50M<0.1%−14,300−2.0%ReducedHolders
Q3 2024724,078$1.95M<0.1%−21,200−2.8%ReducedHolders
Q2 2024745,278$2.12M<0.1%+42,800+6.1%AddedHolders
Q1 2024702,478$2.98M<0.1%−17,900−2.5%ReducedHolders
Q4 2023720,378$3.85M<0.1%−24,300−3.3%ReducedHolders
Q3 2023744,678$3.20M<0.1%−7,529−1.0%ReducedHolders
Q2 2023752,207$4.13M<0.1%+22,200+3.0%AddedHolders
Q1 2023730,007$3.07M<0.1%−4,300−0.6%ReducedHolders
Q4 2022734,307$2.03M<0.1%−117,159−13.8%ReducedHolders
Q3 2022851,466$2.18M<0.1%−149,796−15.0%ReducedHolders
Q2 20221,001,262$3.60M<0.1%+52,817+5.6%AddedHolders
Q1 2022948,445$5.89M<0.1%+42,500+4.7%AddedHolders
Q4 2021905,945$6.39M<0.1%−170,500−15.8%ReducedHolders
Q3 20211,076,445$7.51M<0.1%−156,900−12.7%ReducedHolders
Q2 20211,233,345$10.3M<0.1%−194,300−13.6%ReducedHolders
Q1 20211,427,645$7.79M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.